Kalindjian; Sarkis Barret

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kalindjian; Sarkis Barret.The latest application filed is for "bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (rarbeta) agonists".

Company Profile

2.13.13

Kalindjian; Sarkis Barret - Surrey GB
Kalindjian; Sarkis Barret - Middlesex GB
Kalindjian; Sarkis Barret - London GB
Kalindjian; Sarkis Barret - Banstead Surrey GB
Kalindjian, Sarkis Barret - Dulwich GB
Kalindjian; Sarkis Barret - Banstead GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RAR.beta.) agonists Grant 11,401,265 - Borthwick , et al. August 2, 2	2022-08-02
Bicycloheteroaryl-Heteroaryl-Benzoic Acid Compounds as Retinoic Acid Receptor Beta (RARBeta) Agonists App 20210130337 - Borthwick; Alan David ; et al.	2021-05-06
Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RAR.beta.) agonists Grant 10,752,616 - Borthwick , et al. A	2020-08-25
Bicycloheteroaryl-Heteroaryl-Benzoic Acid Compounds as Retinoic Acid Receptor Beta (RARBeta) Agonists App 20200131165 - Borthwick; Alan David ; et al.	2020-04-30
Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RAR.beta.) agonists Grant 10,385,044 - Borthwick , et al. A	2019-08-20
Bicycloheteroaryl-Heteroaryl-Benzoic Acid Compounds as Retinoic Acid Receptor Beta (RARBeta) Agonists App 20190010146 - Borthwick; Alan David ; et al.	2019-01-10
Compounds Useful As Ccr9 Modulators App 20180230098 - Bakthavatchalam; Rajagopal ; et al.	2018-08-16
Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RAR.beta.) agonists Grant 9,994,559 - Borthwick , et al. June 12, 2	2018-06-12
Compounds useful as CCR9 modulators Grant 9,969,687 - Bakthavatchalam , et al. May 15, 2	2018-05-15
Bicycloheteroaryl-Heteroaryl-Benzoic Acid Compounds as Retinoic Acid Receptor Beta (RARBeta) Agonists App 20170327489 - Borthwick; Alan David ; et al.	2017-11-16
Compounds Useful As Ccr9 Modulators App 20170001959 - Bakthavatchalam; Rajagopal ; et al.	2017-01-05
Benzene Sulfonamides As Ccr9 Inhibitors App 20170002011 - Bakthavatchalam; Rajagopal ; et al.	2017-01-05
Therapeutic aryl-amido-aryl compounds and their use Grant 9,447,028 - Corcoran , et al. September 20, 2	2016-09-20
Therapeutic Aryl-Amido-Aryl Compounds and Their Use App 20160039747 - Corcoran; Jonathan Patrick Thomas ; et al.	2016-02-11
Therapeutic Aryl-Amido-Aryl Compounds and Their Use App 20120149737 - Corcoran; Jonathan Patrick Thomas ; et al.	2012-06-14
Gastrin and cholecystokinin receptor ligands (III) Grant 7,034,048 - Kalindjian , et al. April 25, 2	2006-04-25
Benzotriazepnes as gastrin and cholecystokinin receptor ligands App 20060003993 - McDonald; Iain Mair ; et al.	2006-01-05
Gastrin and cholecystokinin receptor ligands(II) Grant 6,878,734 - Kalindjian , et al. April 12, 2	2005-04-12
Histamine H3 receptor ligands Grant 6,878,736 - Kalindjian , et al. April 12, 2	2005-04-12
Gastrin and cholecystokinin receptor ligands(II) App 20030199565 - Kalindjian, Sarkis Barret ; et al.	2003-10-23
Pharmaceutical compositions comprising proton pump inhibitors and gastrin/cholecystokinin receptor ligands App 20030195240 - Kalindjian, Sarkis Barret ; et al.	2003-10-16
Gastrin and cholecystokinin receptor ligands (III) App 20030191116 - Kalindjian, Sarkis Barret ; et al.	2003-10-09
Gastrin and cholecystokinin receptor ligands Grant 6,479,531 - Kalindjian , et al. November 12, 2	2002-11-12
Sulfonamides and sulfamides as H.sub.3 receptor antagonists Grant 6,080,871 - Kalindjian , et al. June 27, 2	2000-06-27
Gastrin and cck receptor ligands Grant 5,919,829 - Kalindjian , et al. July 6, 1	1999-07-06
Gastrin and CCK antagonists Grant 5,912,260 - Kalindjian , et al. June 15, 1	1999-06-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.